Background {#Sec1}
==========

Diarrhoea remains a serious health burden in children less than 5 years of age in developing countries. Globally, diarrhoea kills around 525,000 children less than 5 years of age each year \[[@CR1]\]. The commonest etiological agents of acute watery diarrhoea in young children in developing countries are rotavirus, enterotoxigenic *Escherichia coli, Shigella* spp.*, Campylobacter jejuni* and *Cryptosporidium parvum* \[[@CR2]\].

Viruses are primary agents of diarrhoea during the winter in developed countries whereas bacteria are the main agents of diarrhoea in rainy season in developing countries \[[@CR3]\]. However, rotavirus is found to be a single dominant enteric pathogen among children in most of the developed and developing countries \[[@CR4]\]. The number of deaths attributable to rotavirus infection and associated disease in children younger than 5 years in 2008 was estimated to be 453,000 (95% CI 420,000-494,000) \[[@CR5]\]. With the introduction of rotavirus vaccine, the number of deaths in children less than 5 years of age declined from 528, 000 in 2000 to 215, 000 in 2013; and decreased the percentage of hospitalization due to acute gastroenteritis caused by rotavirus \[[@CR6], [@CR7]\].

World Health Organization recommended integrating rotavirus vaccine into national immunization program \[[@CR8], [@CR9]\]. Although the incidence of rotavirus infection among children in developed and developing countries is similar, outcomes often vary widely with 82% of fatalities estimated to occur in developing countries \[[@CR6], [@CR10]\]. Rotavirus infections are an important cause of hospitalization, causing significant economic impact on poor countries \[[@CR11]\]. Studies published on rotavirus infection in Nepal from 1999 to 2007 showed rotavirus positivity rates ranged from 17 to 39% among all hospitalized children less than 5 years \[[@CR12]--[@CR15]\]. Various published studies from 2008 to 2017 reported different prevalence rates of rotavirus infections in diarrhoeal children, ranging from 22 to 53% \[[@CR16]--[@CR19]\].

Studies revealed that co-infection does exist between enteric bacteria and viruses \[[@CR20], [@CR21]\]. This evidence collectively demonstrates that co-infection by bacterial and viral pathogens play a critical role in disease progression. Infectious diseases cause most of the child deaths in developing countries \[[@CR22]\], but the etiological agents are usually unknown and can lead to overuse/misuse of antibiotics, which may exacerbate the antibiotic resistance, already a global threat \[[@CR23]\]. This study focuses on co-infection of *Campylobacter* in rotavirus infected children and explores associated risk factors and clinical features.

Methods {#Sec2}
=======

A hospital based cross-sectional study was conducted from November 2017 to April 2018. A total of 303 stool samples were collected from Kanti Children's Hospital (KCH), Kathmandu, Nepal. Written informed consents and clinical and demographic information were obtained from guardians/caretakers of the patient. Samples were collected from children less than 5 years of age, presenting with diarrhoea as reported by parents in hospital. The samples were tested for rotavirus using Onsite rotavirus Ag Rapid Test kit (CTK Biotech, Inc. San Diego, USA) for rapid diagnosis of rotavirus, and the samples were taken in the laboratory for the detection of *Campylobacter* causing infection by culture on *Campylobacter* blood-free selective agar base supplemented with Campy blood free selective medium (Charcoal cefoperazone deoxycholate agar, CCDA) Selective Supplement (SR0155, containing cefoperazone and amphotericin B antibiotics) (Thermo-Fischer, Oxoid, UK). The inoculated medium was incubated at 37 °C and 42 °C in microaerophilic condition for 24 to 48 h using Campy gas pack (Oxoid, UK). After incubation, colonies appeared colorless or grey and spread like droplets. A presumptive diagnosis was made by wet mount preparation for darting motility. The isolated bacteria were identified based on the morphological character of the colonies, Gram staining of the isolate (Staining was performed with the application of carbol fuchsin as gram counter stain for 5 min), oxidase test, catalase test and sensitivity to nalidixic acid (30 μg) to differentiate *Campylobacter* spp. from other Enterobacteriaceae. Hippurate hydrolysis test was performed for differentiation of *Campylobacter* spp. A total of 4 days was required for confirmed diagnosis of infection with *Campylobacter*. Modified Kirby-Bauer Disc diffusion technique was used for testing the susceptibility pattern of different isolates towards various classes of antibiotics in Mueller Hinton Agar (MHA) with 5% defibrinated sheep blood. Antibiotics were used according to EUCAST guidelines (2015). Data analysis was done using IBM Statistical Package for Social Sciences version 20.0 (SPSS, Inc., Chicago, IL, USA). The association among co-infection and mono-infection with rotavirus and *Campylobacter* was tested using the Chi-square test for differences in proportions; and logistic regression analysis was used to assess the association between infection and the risk factors. A *p*-value less than0.05 was considered statistically significant.

Results {#Sec3}
=======

The study included three hundred and three diarrhoeal children less than 5 years of age during the study period. The highest number of patients (*n* = 118) were from age group 7--12 months. There were 207 (68.3%) male and 96 (31.7%) female patients.

Detection rate of pathogens {#Sec4}
---------------------------

The study was focused on detection of rotavirus and *Campylobacter* spp., and at least one of these pathogens were detected in 233 (76.9%) samples. Among 303 children with acute watery diarrhea, rotavirus mono-infection was detected in 61 (20.1%), *Campylobacter* mono-infection was detected in 81 (26.7%), co-infection was detected in 91 (30.0%) (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1Prevalence of *Campylobacter* and rotavirus mono- and co-infections and other infections, Nepal, 2017/18. \*Other means Other than rotavirus and *Campylobacter* infection

Age wise distribution of different infections in children {#Sec5}
---------------------------------------------------------

The highest number of rotavirus mono-infection was detected in 7--12 months age group category which accounted 29 (47.5%) of total rotavirus mono-infection. Similarly, highest number of *Campylobacter* mono-infection 34 (42.0%) was found in the \< 6 months age group. The co-infection was observed highest (35, 38.5%) in 7--12 months of age (Table [1](#Tab1){ref-type="table"}). Distribution of different infections in children less than 5 years was not statistically significant (χ^2^test, *p* \> 0.05). Table 1Age-related distribution of *Campylobacter* and rotavirus mono- and co-infectionsAge (months)Type of infectionRotavirus only n (%)*Campylobacter* only n (%)Co-infections n (%)Undetected n (%)\< 614 (23.0)34 (42.0)26 (28.6)19 (27.1)7--1229 (47.5)29 (35.8)35 (38.5)25 (35.7)13--2410 (16.4)7 (8.6)19 (20.9)13 (18.6)25--363 (4.9)6 (7.4)7 (7.7)5 (7.1)37--605 (8.2)5 (6.2)4 (4.4)8 (11.4)Total61 (100.0)81 (100.0)91 (100.0)70 (100.0)

Risk factors for different infections in children {#Sec6}
-------------------------------------------------

In multivariate analysis, infection in February was associated with a decreased risk of rotavirus mono-infection \[adjusted odds ratio (AOR) = 0.26, 95% CI = 0.07--0.98, *p* = 0.047\] than in November. Except for the age group of 25--36 months, all age groups were significantly associated with decreased risk of *Campylobacter* mono-infection compared to \< 6 months age. No soil contact (AOR = 0.06, 95%CI = 0.01--0.47, *p* = 0.008) was significantly associated with a decreased risk of *Campylobacter* mono-infection compared to frequent soil contact. Infection in January (AOR = 11.34, 95%CI = 1.27--101.27, *p* = 0.030) and February (AOR = 25.32, 95%CI = 2.68--238.69, *p* = 0.005) were significantly associated with a higher risk of co-infections compared to November (Table [2](#Tab2){ref-type="table"}). Table 2Risk factors for Rotavirus and *Campylobacter* mono-infection and co-infection in multivariate analysisRisk factorsRotavirus monoinfection*Campylobacter* monoinfectionCo-infectionAOR (95%CI)*P* -valueAOR (95%CI)*P*-valueAOR (95%CI)*P*-valueMonths November111 December0.59 (0.15--2.30)0.4515.57 (0.56--54.98)0.1418.98 (0.94--85.86)0.057 January0.39 (0.11--1.30)0.1276.06 (0.68--53.96)0.10611.34 (1.27--101.27)0.030^a^ February0.26 (0.07--0.98)0.047^a^5.36 (0.58--48.94)0.13725.32 (2.68--238.69)0.005^a^Age (in months)  \< 6111 7--121.70 (0.39--7.33)0.4710.19 (0.04--0.90)0.037^a^1.26 (0.32--4.87)0.738 13--241.64 (0.31--8.49)0.5530.07 (0.01--0.42)0.004^a^1.42 (0.31--6.45)0.649 25--363.28 (0.23--45.27)0.3740.10 (0.01--1.21)0.0700.89 (0.09--8.20)0.925 37--606.04 (0.33--107.97)0.2210.04 (0.01--0.73)0.029^a^0.47 (0.03--5.74)0.556*Sex* Male1--11 Female1.09 (0.52--2.26)0.8170.90 (0.42--1.90)0.7911.59 (0.80--3.12)0.179Parent's occupation Agriculture0.40 (0.13--1.21)0.1071.09 (0.31--3.86)0.8862.62 (0.90--7.66)0.077 Service0.55 (0.15--1.96)0.3591.30 (0.32--5.29)0.7071.92 (0.53--6.90)0.318 Business0.82 (0.24--2.82)0.7591.35 (0.36--4.96)0.6510.70 (0.21--2.34)0.569 Others111Breast feed No0.30 (0.04--2.11)0.2301.63 (0.34--7.72)0.5341.18 (0.29--4.74)0.814 Yes111*Water source* Non-pipe borne111 Pipe borne0.70 (0.27--1.75)0.4480.95 (0.39--2.30)0.9241.00 (0.45--2.22)0.997Drinking water Untreated111 Boiled0.81 (0.28--2.28)0.6950.64 (0.21--1.94)0.4381.47 (0.55--3.89)0.436 Filtered0.24 (0.03--1.56)0.13700.9984.45 (0.92--21.33)0.062 Chlorinated0.70 (0.22--2.22)0.5500.78 (0.25--2.46)0.6811.45 (0.50--4.16)0.487Soil contact No soil contact1.86 (0.35--9.84)0.4600.06 (0.01--0.47)0.008^a^3.02 (0.62--14.73)0.171 Infrequently1.39 (0.51--3.75)0.5100.49 (0.18--1.33)0.1621.01 (0.41--2.42)0.990 Frequently111Hygiene Poor111 Good0.45 (0.16--1.24)0.1250.97 (0.33--2.80)0.9641.01 (0.40--2.55)0.973Parent's education level Illiterate00.99900.99900.999 Literate0.57 (0.19--1.72)0.3240.78 (0.24--2.53)0.6872.12 (0.72--6.22)0.169 Higher level111*AOR* Adjusted odds ratio, 95% *CI* 95% confidence interval, 1 = Reference, *P* \< 0.05 was considered significant,^a^ = significant

Clinical features in different infections with diarrhea {#Sec7}
-------------------------------------------------------

Among children with diarrhoea, clinical presentations were as follows: 23.8, 49.2 and 27.1% cases had 3--6, 7--9 and \> 9 loose motions/day respectively. 64.7% cases had fever, and 85.8% had vomiting. 75.2% had no dehydration, 23.8% had mild to moderate dehydration and 1% had severe dehydration. 31.4% cases had abdominal pain. 35.6% had diarrhoea for less than 3 days, 45.9% had diarrhoea for 3--5 days, 17.5% had diarrhoea for 6--9 days, and only 1% had diarrhoea for more than 9 days. 70.6% of patients were from Out Patient Department (OPD) and only 29.4% were from In Patient Department (IPD). 60.7% had mucus in the stool and 30.0% had pus cells in the stool.

Abdominal pain and presence of pus cells in stool were less common features, which were significantly associated with rotavirus mono-infection in multivariate analysis. Pus cells in stool was common clinical feature, while fever and vomiting were less prevalent but significantly associated with *Campylobacter* mono-infection in multivariate analysis. More than nine loose motions per day, fever, vomiting, and presence of mucus in stool were most striking clinical features. Mild to moderate dehydration were less common compared with no dehydration but were significantly associated with co-infections in multivariate analysis (Table [3](#Tab3){ref-type="table"}). Table 3Clinical features in different infections in multivariate analysisClinical featuresRotavirus only*Campylobacter* onlyCo-infectionAOR (95%CI)*p*-valueAOR (95%CI)*p*-valueAOR (95%CI)*p*-valueStool/day 3--62.60 (0.79--8.55)0.1151.42 (0.47--4.22)0.5260.06 (0.01--0.23)\< 0.001 7--91.57 (0.56--4.38)0.3850.98 (0.38--2.52)0.9710.33 (0.13--0.85)0.021  \> 9111Fever No1.39 (0.69--2.79)0.3552.07 (1.12--3.83)0.0200.25 (0.12--0.50)\< 0.001 Yes111Vomiting No0.51 (0.16--1.57)0.2414.48 (1.99--10.09)\< 0.0010.26 (0.07--0.88)0.005 Yes111Dehydration No-minimal111 Mild-moderate2.53 (0.98--6.52)0.0531.22 (0.47--3.15)0.6750.29 (0.12--0.73)0.009 Severe00.99900.99900.999Abdominal pain No2.53 (1.16--5.52)0.0191.41 (0.75--2.62)0.2790.52 (0.27--1.01)0.051 Yes111Duration of diarrhea (in days)  \< 3111 3--50.87 (0.41--1.87)0.7371.02 (0.52--1.96)0.9520.66 (0.33--1.31)0.241 6--90.67 (0.24--1.89)0.4580.54 (0.21--1.41)0.2111.68 (0.67--4.16)0.262  \> 900.9992.15 (0.13--33.69)0.58400.999Mucus Absent1.39 (0.74--2.61)0.3990.81 (0.45--1.49)0.5140.46 (0.25--0.86)0.016 Present111Pus Absent7.26 (2.47--21.36)\< 0.0010.45 (0.25--0.81)0.0080.81 (0.43--1.50)0.508 Present111*AOR* Adjusted odds ratio, 95%*CI* 95% confidence interval, *NA* Not applicable, 1 = Reference

Antibiotic resistance patterns in *Campylobacter* spp. {#Sec8}
------------------------------------------------------

A total of 172 *Campylobacter* isolates were tested for antibiotic susceptibility. Among them, resistance to different antibiotics were: ampicillin (93.6%), cephalexin (88.4%), erythromycin (73.8%), nalidixic acid (72.1%) and cotrimoxazole (59.9%). Resistance to ampicillin/sulbactam, norfloxacin, azithromycin and tetracycline were 35.1, 40.1, 46.5 and 47.1% respectively. *Campylobacter* isolates were resistant to gentamicin (11.6%), chloramphenicol (15.7%) and ciprofloxacin (35.1%) (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Antibiotic resistance patterns in isolated *Campylobacter* spp. (*n* = 172)

Discussion {#Sec9}
==========

This hospital based cross sectional study explored the association between *Campylobacter* and rotavirus infections, possible risk factors and specific clinical features. In this study, most cases of acute gastroenteritis were infants. Past studies have echoed with our study that shows that diarrhea incidence peaks at age 6--11 months \[[@CR24]--[@CR26]\].

Our study identified that a higher frequency of diarrhoea was seen in males consistent with other studies \[[@CR13], [@CR16], [@CR27], [@CR28]\]. Males' preponderance to develop diarrhoea can be explained by their increased susceptibility to outdoor physical activities thus exposure to unhygienic surroundings and flood-water during rainy seasons. In addition, it could be due to simply increased presentation of male patients at the hospital more than females \[[@CR29]\].

*Campylobacter* and rotavirus co-infections were responsible for the one third of acute gastroenteritis cases among children less than 5 years of age visiting at the OPD and IPD clinic/vaccination unit at the KCH in Kathmandu, Nepal during November 2017--April 2018. This study confirmed previous studies where *Campylobacter* co-infection with rotavirus in children were high in less than 5 years of age \[[@CR30], [@CR31]\].

*Campylobacter* spp. isolation in diarrhoeal cases was high. *Campylobacter* is not included in the routine diagnosis protocol thus obviates the routine laboratory investigations on the important causative agents of diarrhoea in Nepal. *Campylobacter* was most prevalent in February. Rotavirus mono-infection was detected in one-fifth of the children, highest in the age group: 7--12 months and was consistent with other studies in Nepal and South-East Asian countries \[[@CR19], [@CR32]\], however, findings contrasted with few other studies from Nepal \[[@CR16], [@CR18]\]. It appears that infants less than 6 months of age were initially protected against severe diarrhoea, to some extent, by maternal antibodies and they seem to have acquired adequate immunity between 12 and 16 months of age \[[@CR16]\].

Age, sex, breast feeding, water source, quality of drinking water, hygiene and education level of parents were not found to predict rotavirus mono-infection in these children. While the month of diarrhoeal illness does possess a risk for rotavirus mono-infection, a higher infection during January--February contradicts with one past study \[[@CR19]\]. In our study, age group was the significant predictor of *Campylobacter* mono-infection. No soil contact was associated with a reduced risk of Campylobacteriosis compared to frequent soil contact. In Nepal, *Campylobacter* is not included in routine microbiological testing in patients with diarrhoea. Conventional culture of *Campylobacter* is time consuming and hence affects the management of diarrhoeal cases. Therefore, use of rapid sensitive molecular techniques could be useful for timely management of Campylobacteriosis \[[@CR33]\].

In multivariate analysis, clinical picture of children with co-infection was more severe compared to mono-infection for most clinical signs taken into examination that included fever, vomiting, abdominal pain, duration of illness, hospitalization, frequency of loose motion/day and presence of mucus in stool. Our observations are consistent with a study among Korean children \[[@CR34]\]. We observed that especially with rotavirus and *Campylobacter* co-infections, there was an increase in the episodes of loose motions per day, which is consistent with a study in Odisha, India \[[@CR32]\]. A study reported from China revealed synergistic effect due to co-infection in severe childhood diarrhoea \[[@CR35]\].

Increasing antimicrobial drug resistance by *Campylobacter* limits the number of therapeutic options, which makes empirical treatment more difficult. High proportions of antibiotic resistant *Campylobacter* isolates in our study reveals either there is antibiotic pressure or transmission of resistant bacteria from foods of animal origin \[[@CR36]\].

Conclusion {#Sec10}
==========

In conclusion, this hospital-based cross-sectional study highlights the burden of rotavirus, *Campylobacter* and co-infections in childhood diarrhoea in Nepal. Rotavirus and *Campylobacter* associated co-infections were found to be high in this study. *Campylobacter* spp., which are generally not screened for in diarrheic patients in Nepal, should also be suspected and considered into the routine diagnosis protocol. Diagnosis of the right causative agents among possible multiple infectious etiologies can help to better manage the acute childhood diarrhoea.
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